Inmode Ltd

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

InMode reports record revenue, plans global expansion for growth

InMode's strong financial performance in Q4 and full year 2022, driven by successful product launches and global expansion efforts, positions the company for continued growth. Despite challenges in pinpointing market penetration, opportunities lie in new product launches and untapped physician markets.

InMode reports robust Q1 earnings, eyes international expansion and talent

InMode delivered strong Q1 2023 results, driven by revenue growth, international expansion, and strategic hiring practices, positioning the company for continued success.
While facing challenges such as rising operating expenses and talent acquisition complexities, InMode's focus on quality, innovation, and financial strength presents opportunities for sustainable growth.
By leveraging opportunities in talent acquisition, product innovation, and international expansion, InMode can enhance market competitiveness and drive long-term value creation.
Overall, InMode's performance, strengths, and strategic outlook indicate a positive trajectory for future growth and profitability, supported by a solid financial foundation.

InMode achieves record Q2 earnings, eyes global expansion and innovation

InMode's strong financial performance, global expansion, and focus on innovation position it well for future growth. While facing challenges in managing increased expenses and scaling sales, the company's strategic investments and market positioning offer promising opportunities for expansion and market leadership.

InMode reports steady Q3 growth amidst challenges and opportunities

InMode's Q3 performance reflects resilience amid industry seasonality and macro challenges, with revenue growth and strong margins.
The company's focus on innovation, IP protection, and strategic acquisitions positions it for sustained leadership and growth.
Challenges in leasing processes and legal battles require proactive management, but opportunities in M&A and product growth remain.
Despite uncertainties for 2024, InMode's strategic initiatives and market presence offer a foundation for future success.

InMode reports record 2023 revenue, eyes international expansion and M&A

InMode navigated industry challenges in 2023 with resilience, focusing on innovation, global expansion, and cost management. Despite facing headwinds, the company remains optimistic about growth opportunities, leveraging its strong financial position and strategic initiatives for future success.

InMode reports Q1 revenue of $80.3M, adjusts guidance for 2024

InMode faces challenges from industry headwinds and manufacturing delays but shows strength in new platform launches and North America performance.
Opportunities lie in strategic initiatives, market demand confidence, and growth potential from new platforms.
Guidance adjustments reflect proactive measures to navigate uncertainties and drive future growth.
Overall, InMode remains resilient amidst challenges, poised for growth with strategic focus areas.

InMode reports Q2 revenue of $86.4 million, adjusts 2024 guidance

InMode faces challenges with declining demand for treatments and international sales, but is leveraging new platform launches and cost management to drive performance. The company is adapting to market conditions and geopolitical issues to capitalize on growth opportunities.

InMode reports Q3 revenue of $130.2M, revises guidance amid challenges

InMode faced challenges from macroeconomic headwinds, impacting international sales and necessitating a revision of full-year guidance.
Despite these challenges, the company demonstrated strong operational performance with high gross margins and strategic management changes.
Opportunities lie in new platform adoption, market realignment, and leveraging the strong cash position for future growth.
Overall, InMode remains well-positioned to navigate challenges and capitalize on opportunities for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74645&wire=1 or contact Joseph E.

Levi & Korsinsky Notifies Shareholders of InMode Ltd.(INMD) of a Class Action Lawsuit and an Upcoming Deadline

LOS ANGELES, CA / ACCESSWIRE / April 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against InMode Ltd. ("InMode" or "the Company") (NASDAQ:INMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / April 7, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74643&wire=1 or contact Joseph E.

InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMD

NEW YORK , April 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of InMode Ltd. (NASDAQ: INMD).

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2024 in InMode Ltd. Lawsuit - INMD

NEW YORK, NY / ACCESSWIRE / April 5, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74417&wire=1 or contact Joseph E.

Shareholders that lost money on InMode Ltd. (INMD) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK , April 4, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against InMode Ltd. ("InMode" or the "Company") (NASDAQ: INMD) and reminds investors of the April 15, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InMode

NEW YORK, NY / ACCESSWIRE / April 4, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74207&wire=1 or contact Joseph E.

Shareholders that lost money on InMode Ltd.(INMD) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

In the most recent trading session, InMode (INMD) closed at $20.62, indicating a +0.05% shift from the previous trading day.

InMode (INMD) Ascends But Remains Behind Market: Some Facts to Note

NEW YORK, NY / ACCESSWIRE / April 3, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74153&wire=1 or contact Joseph E.

Class Action Filed Against InMode Ltd. (INMD) Seeking Recovery for Investors – Contact Levi & Korsinsky

YOKNEAM, Israel , April 3, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in April and May: 23rd Annual Needham Virtual Healthcare Conference Presenters: Moshe Mizrahy, Chief Executive Officer and Chairman, Yair Malca, Chief Financial Officer and Spero Theodorou, Chief Medical Officer Format: Virtual fireside chat moderated by Michael Matson, CFA and Senior Equity Research Analyst and one-on-one meetings When: Tuesday, April 9 at 8:00 am ET A live webcast of the presentation can be accessed here.

InMode to Present at Upcoming Investor Conferences and Events

NEW YORK, NY / ACCESSWIRE / April 3, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74040&wire=1 or contact Joseph E.

April 15, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - INMD

NEW YORK, NY / ACCESSWIRE / April 3, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=74020&wire=1 or contact Joseph E.

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of InMode Ltd.(INMD) Shareholders

LOS ANGELES, CA / ACCESSWIRE / April 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against InMode Ltd. ("InMode" or "the Company") (NASDAQ:INMD) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / April 2, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=73978&wire=1 or contact Joseph E.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 15, 2024 in InMode Ltd. Lawsuit – INMD

NEW YORK, NY / ACCESSWIRE / April 2, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=73961&wire=1 or contact Joseph E.

Shareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights – INMD

NEW YORK, NY / ACCESSWIRE / April 2, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=73913&wire=1 or contact Joseph E.

InMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights – INMD

LOS ANGELES, CA / ACCESSWIRE / April 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against InMode Ltd. ("InMode" or "the Company") (NASDAQ:INMD) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $100,000 to Contact the Firm

NEW YORK , April 2, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of InMode Ltd. (NASDAQ: INMD).

April 15, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INMD

NEW YORK, NY / ACCESSWIRE / April 1, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=73730&wire=1 or contact Joseph E.

Levi & Korsinsky Notifies Shareholders of InMode Ltd. (INMD) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / April 1, 2024 / If you suffered a loss on your InMode Ltd. (NASDAQ:INMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inmode-lawsuit-submission-form?prid=73696&wire=1 or contact Joseph E.

Investors who lost money on InMode Ltd.(INMD) should contact Levi & Korsinsky about pending Class Action - INMD

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic?

Recently, Zacks.com users have been paying close attention to InMode (INMD). This makes it worthwhile to examine what the stock has in store.

InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know

LOS ANGELES, CA / ACCESSWIRE / April 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against InMode Ltd. ("InMode" or "the Company") (NASDAQ:INMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses In Excess of $100,000 to Contact the Firm

NEW YORK , March 31, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the "Class Period"), of the important April 15, 2024 lead plaintiff deadline.

TOP RANKED ROSEN LAW FIRM Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD

NEW YORK, March 29, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against InMode Ltd. ("InMode" or the "Company") (NASDAQ: INMD) and reminds investors of the April 15, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

News for Inmode Ltd Stock (INMD)